GENDER SPECIFIC DIFFERENCES IN ANKYLOSING SPONDYLITIS AT TREATMENT INITIATION IN PATIENTS TREATED WITH INFLIXIMAB OR GOLIMUMAB

被引：0
|
作者：
Starr, M. [1 ]
Zummer, M. [2 ]
Choquette, D. [3 ]
Haraoui, B. [3 ]
Rahman, P. [4 ]
Sheriff, M. [5 ]
Rampakakis, E. [6 ]
Psaradellis, E. [6 ]
Osborne, B. [7 ]
Lehman, A. J. [7 ]
Maslova, K. [7 ]
Nantel, F. [7 ]
Tkaczyk, C. M. [7 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Hop Maison Neuve Rosemont, Montreal, PQ, Canada
[3] Inst Rhumatol Montreal, Montreal, PQ, Canada
[4] Mem Univ, St John, NF, Canada
[5] Nanaimo Reg Hosp, Nanaimo, BC, Canada
[6] JSS Med Res, Montreal, PQ, Canada
[7] Janssen, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4740
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0684
引用
收藏
页码：1138 / 1139
页数：2
相关论文
共 50 条
  • [41] Phlegmonous gastritis in an ankylosing spondylitis patient treated with infliximab
    Kim, Bo Young
    Kim, Hyun-Sook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (05): : 945 - 946
  • [42] Infliximab treatment in ankylosing spondylitis: an observational study
    Nikas, SN
    Alamanos, Y
    Voulgari, PV
    Pliakou, XI
    Papadopoulos, CG
    Drosos, AA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (06) : 940 - 942
  • [43] Infliximab in the treatment of active and severe ankylosing spondylitis
    Brandt, J
    Sieper, J
    Braun, J
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (06) : S106 - S110
  • [44] Bisphosphonates vs Infliximab in Ankylosing Spondylitis Treatment
    Lunzer, R.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2014, 21 (01): : 38 - 38
  • [45] Bisphosphonates vs infliximab in ankylosing spondylitis treatment
    Viapiana, Ombretta
    Gatti, Davide
    Idolazzi, Luca
    Fracassi, Elena
    Adami, Silvano
    Troplini, Sonila
    Povino, Maria Rosaria
    Rossini, Maurizio
    RHEUMATOLOGY, 2014, 53 (01) : 90 - 94
  • [46] BISPHOSPHONATES VERSUS INFLIXIMAB IN ANKYLOSING SPONDYLITIS TREATMENT
    Viapiana, O.
    Fracassi, E.
    Caimmi, C.
    Idolazzi, L.
    Dartizio, C.
    Zampieri, R.
    Montanari, I.
    Troplini, S.
    Povino, M. R.
    Orsolini, G.
    Gatti, D.
    Rossini, M.
    Adami, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 946 - 946
  • [47] Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab
    Choquette, Denis
    Bessette, Louis
    Raynauld, Jean-Pierre
    Pelletier, Jean-Pierre
    Haraoui, Boulos
    Villeneuve, Edith
    Massicotte, Frederic
    Remillard, Marie-Anais
    Sauvageau, Diane
    Coupal, Louis
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1345 - 1345
  • [48] Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis
    Stone, M
    Salonen, D
    Lax, M
    Payne, U
    Lapp, V
    Inman, R
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (07) : 1605 - 1614
  • [49] Antiphospholipid and antinuclear antibodies following infliximab treatment in patients with ankylosing spondylitis
    Atzeni, F
    Sarzi-Puttini, P
    Randisi, G
    Marrazza, MG
    Carrabba, M
    Capsoni, F
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 642 - 642
  • [50] Infliximab therapy for patients with ankylosing spondylitis: on-demand or continuous treatment?
    Sieper, Joachim
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (08): : 398 - 399
12345